Partner

Final analysis Lightsite 1 a double masked randomized sham controlled single center study with PBM for the treatment of AMD

La fotobiomodulazione nel trattamento della degenerazione maculare senile atrofica una nuova prospettiva terapeutica

Improvement of visual function following multi-wavelength PBM with the Valeda Light Delivery System on electroretinography and best corrected visual acuity in dry AMD in the Electrolight study

Lighsite 2 randomized multicenter trial evaluation of multiwavelength PBM in non exudative AMD

Lightsite 3 24 month analysis evaluation of multiwavelength PBM in dry AMD using the LumiThera Valeda Light Delivery System

Non-Invasive Treatment of Early Diabetic Macular Edema by Multiwavelength Photobiomodulation with the Valeda Light Delivery System

PBM reduces drusen volume and improves AV and SC in dry age-related macular degeneration

Photobiomodulation as an Innovative and Promising Treatment for Retinal Disease

Photobiomodulation for non-exudative age-related macular degeneration

Photobiomodulation therapy for AMD and Diabetic Retinopathy

Photobiomodulation therapy for large soft drusen and drusenoid pigment epithelial detachment in dry AMD

Photobiomodulation for the treatment of retinal diseases

Progress of clinical therapies for dry AMD

Shedding light on photobiomodulation therapy for AMD

The present and future of mitochondrial based therapeutics for eye disease.pdf

Treatment of dry Age-related Macular Degeneration with Photobiomodulation

13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System